Studies colon and rectum surgery in people with retroperitoneal sarcoma
Observes bowel removal and reconstruction methods in adults with retroperitoneal sarcoma.
Key facts
- Who runs it
- Heidelberg University
- Where
- Basel, SwitzerlandSee the siteAlso in 1 other country, 15 sites
- Trial code
- NCT06943612
- DRKS00034135
- Registry title
- Colorectal Resections in Patients With Retroperitoneal Sarcoma
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 27 Jan 2025
- Planned end
- 5 Nov 2026
- Type of study
- Observational
- Record updated
- 23 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a confirmed retroperitoneal sarcoma who had the tumor removed together with part of the colon or rectum.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Retroperitoneal sarcoma confirmed by tissue examination (histology).
- Earlier treatment
- Tumor removal surgery that included a colorectal resection, done at a DKG-certified sarcoma center or a hospital that meets equivalent criteria.
Main reasons for not taking part
- No written consent
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Histological confirmation with evidence of a retroperitoneal sarcoma
- Tumor resection with colorectal resection
- Surgery in a DKG-certified sarcoma center or hospital that meets certification-equivalent criteria
- Age 18 years or older
- Written consent
Who cannot take part
- Absence of consent
This trial is currently available in Switzerland.
Also in 1 other country, 15 sites
- Sarcoma Center University of BaselBasel, SwitzerlandContact: Alexander Willhelm, Dr.Taking people
About the trial
What the trial wants to find out
COLOSARC-Q is a multicenter study with the objective of providing an up-to-date assessment of colorectal resections and reconstruction techniques in the context of multivisceral resections for retroperitoneal sarcomas, as well as colorectal surgery-associated complications and their impact on patients' quality of life.
Read full original descriptionShow less
In multivisceral resections involving the colon and rectum, the primary aim is to achieve complete resection and preserve organ function. However, multivisceral resections have a high risk of perioperative morbidity including anastomotic leakage. The proposed project aims to determine the number of primary anastomoses, their insufficiency rates, and the fraction of patients with primary and secondary stomas. In addition, the patients' quality of life after multivisceral sarcoma resection is to be recorded using standardized surveys.
The analysis has the potential to facilitate intraoperative decision-making for colorectal resections in the context of multivisceral resections.
The group in the trial
- Patients with primary, retroperitoneal sarcomas who underwent surgery with colorectal resection
Patients with primary retroperitoneal sarcomas who underwent surgery with colorectal resection at DKG-certified sarcoma centers or hospitals in Germany and Switzerland that meet certification-equivalent criteria
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Colorectal Resections and Reconstructions in Patients With Retroperitoneal Sarcoma: Evaluation of Surgical Strategies and Postoperative Quality of Life
- Plain-language title
- Studies colon and rectum surgery in people with retroperitoneal sarcomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 23 July 2026